Abstract Body

Background:

Multi-specific responses have been described in rare people who evolved broadly neutralizing antibody (bnAb) activity in HIV-1 infection but their relevance remains unclear. Here we screened the Swiss HIV Cohort Study for multi-specificity by examining the XbnAb cohort comprising bnAb inducers (N=304) identified in the Swiss 4.5k Screen (Rusert Nat Med 2016).

Methods:

Plasma neutralization fingerprints of bnAb inducers were evaluated against a 41-virus multiclade panel and compared to reference fingerprints of known bnAbs using an established Spearman based correlation method and a novel delineation strategy, termed virus panel classification, we developed to record multi-specificity. BCR were cloned from 16 cases by 10xGenomics and bnAbs of interest epitope mapped (mutational scanning, competition binding, mutant neutralization, cryo-EM).

Results:

Classical bnAb plasma delineation of the XbnAb cohort assigned a single bnAb activity in 90% of plasmas. As the prediction records a dominant activity, secondary multi-specific activity cannot be excluded also in successfully assigned plasmas. This hidden extent of multi-specificity can be substantial as shown by elite neutralizer S51434, a Subtype B infected, slow progressor with predicted silent face activity based on the Spearman correlation method, from which we identified five distinct bnAb types as CD4bs, MPER, a fusion peptide/interface, PGT145-like and a novel V3-glycan bnAb type, with moderate to high breadth (44 – 80%). Virus panel prediction, we developed a novel delineation strategy for multi-specific responses, correctly classified S51434 as multi-specific. Across the XbnAb cohort the virus panel strategy identified a high proportion of bnAb inducers with one dominant bnAb activity (203/304) alongside a substantial number of individuals with multi-specificity (101/304), comprising mostly 2 to 3 predicted bnAb specificities. Extending the comparison of cloned bnAbs and specificity calling by the virus panel method to in total 16 bnAb inducers, substantiates the wide occurrence of multi-specificity.

Conclusions:

Employing a new bnAb specificity prediction tool, the virus-panel fingerprinting method, we demonstrate that multi-specific bnAb activities are common in HIV-1 infection and can lead to elite neutralization. Our findings call for a paradigm shift in the evaluation of bnAb responses, where multi-specificity must be considered as likely as single-specificity and should become the ultimate goal of vaccine-induced responses.